The Supreme Court upheld access to mifepristone, rejecting a challenge by anti-abortion groups, citing lack of standing for the plaintiffs.
The challenge before the court centered on changes the F.D.A. put in place in 2016 and 2021, broadening distribution of the pill by easing patients' ability to receive it through telemedicine and mail.
At oral arguments, a majority of the justices appeared deeply skeptical of efforts to severely curtail access to a widely used abortion pill, questioning whether a group of anti-abortion doctors and organizations had a right to bring a lawsuit in the first place.
Abortion rights groups reacted with wary relief. The attacks on abortion pills will not stop here, Nancy Northup, the president of the Center for Reproductive Rights, said in a statement.
[
Collection
]
[
|
...
]